Pathgroup To Deliver New Tools To Community Oncologists For Advancing Personalized Medicine

Brentwood, Tenn.- (September 13, 2013) – PathGroup, one of the largest private providers of pathology services in the United States, announced today that it will begin offering Next-Generation Sequencing (NGS) and Cytogenomic Array (Array-Based Comparative Genomic Hybridization [aCGH]) for genetic profiling of cancer patients in late Q3 of this year. PathGroup’s SmartGenomics™ Profile will provide community-based oncologists with access to tests and data to make more precise, personalized therapeutic recommendations.

For Full Release, please CLICK HERE